Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

Danish Medicines Agency strengthens its organisational foundation to prepare for tomorrow's tasks

11 November 2025

As of 1 January 2026, a new structure will facilitate cross-disciplinary collaboration and prepare the agency for tomorrow’s tasks within especially four strategic areas. The new structure is also welcoming a new division for preparedness and supply.

Beware of websites and social medial posts misusing the Danish Medi-cines Agency logo

21 August 2025

The Danish Medicines Agency requires bioequivalence data in a better data format

03 July 2025

First common Nordic packages in English approved

20 March 2025